HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway
Open Access
- 1 May 2006
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 116 (5) , 1435-1442
- https://doi.org/10.1172/jci27602
Abstract
Genetic deficiency or inhibition of cholesteryl ester transfer protein (CETP) leads to a marked increase in plasma levels of large HDL-2 particles. However, there is concern that such particles may be dysfunctional in terms of their ability to promote cholesterol efflux from macrophages. Recently, the ATP-binding cassette transporter ABCG1, a macrophage liver X receptor (LXR) target, has been shown to stimulate cholesterol efflux to HDL. We have assessed the ability of HDL from subjects with homozygous deficiency of CETP (CETP-D) to promote cholesterol efflux from macrophages and have evaluated the role of ABCG1 and other factors in this process. CETP-D HDL-2 caused a 2- to 3-fold stimulation of net cholesterol efflux compared with control HDL-2 in LXR-activated macrophages, due primarily to an increase in lecithin:cholesterol acyltransferase–mediated (LCAT-mediated) cholesteryl ester formation in media. Genetic knockdown or overexpression of ABCG1 showed that increased cholesterol efflux to CETP-D HDL was ABCG1 dependent. LCAT and apoE contents of CETP-D HDL-2 were markedly increased compared with control HDL-2, and increased cholesterol esterification activity resided within the apoE-HDL fraction. Thus, CETP-D HDL has enhanced ability to promote cholesterol efflux from foam cells in an ABCG1-dependent pathway due to an increased content of LCAT and apoE.Keywords
This publication has 44 references indexed in Scilit:
- Apolipoprotein E Is the Major Physiological Activator of Lecithin−Cholesterol Acyltransferase (LCAT) on Apolipoprotein B LipoproteinsBiochemistry, 2004
- A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderlyJournal of Lipid Research, 2004
- Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbitsAtherosclerosis, 2004
- ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory ProteinJournal of Biological Chemistry, 2001
- Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levelsJournal of Clinical Investigation, 1999
- A Low Prevalence of Coronary Heart Disease among Subjects with Increased High-Density Lipoprotein Cholesterol Levels, Including Those with Plasma Cholesteryl Ester Transfer Protein DeficiencyPreventive Medicine, 1998
- Plasma Kinetics of Cholesteryl Ester Transfer Protein in the RabbitArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Cholesterol Efflux, Cholesterol Esterification, and Cholesteryl Ester Transfer by LpA-I and LpA-I/A-II in Native PlasmaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.Journal of Clinical Investigation, 1994
- Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-.beta.-high-density lipoprotein pathwayBiochemistry, 1992